Pharma-hedge-douche: I should've charged more for AIDS/cancer drug

Martin Shkreli, the most hated man on the Internet, regrets that he jacked up the price of the off-patent drug Daraprim, taken mainly by people with AIDS and cancer, by a mere 5,000%.

He says that "I could have raised it higher and made more profits for our shareholders, which is my primary duty."

He's confirmed his membership in the sinister cult of fiduciary duty, which views humanity as the inconvenient gut-flora of immortal, transhuman corporations.

But at Thursday's summit, Shkreli was painfully clear: His job isn't making patients better. It's making the most dollars.

"My shareholders expect me to make the most profit," Shkreli said, a theme that he returned to again and again. "That's the ugly, dirty truth."

"I'm going to maximize profits," Shkreli added later. "That's what people [in healthcare] are afraid to say."

Martin Shkreli Admits He Messed Up: He Should've Raised Prices Even Higher
[Dan Diamond/Forbes]